Dark Reading

Biomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT Platform

The launch follows the acquisition of catalog's assets and the appointment of Laurent Guengant as CEO earlier this year.

By Dark Reading

1 min read
Biomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT Platform
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Cybersecurity, Cryptography & Digital Trust

Related Insights